Mesenchymal stem cells may eventually be able to grow and strengthen muscles in humans, according to researchers at the University of Illinois. In mice, an injection of such stem cells helped rejuvenate skeletal muscle after exercise.
Investigators at the University of Wisconsin-Madison have figured out a way to genetically program stem cells into both red and white cells that make up human blood.
Researchers have figured out a way to identify stem cells in tissue from deceased human donors and use them to regrow anatomically correct, fully functional human corneas in mice.
A chemical switch that controls the transformation of neural stem cells into neurons and keeps existing nerve cells in the brain alive may be a viable target for neurodegenerative disorders such as Alzheimer's, Parkinson's and autism.
Researchers from ImStem Biotechnology, University of Connecticut Health Center and Advanced Cell Technology have successfully treated mice with multiple sclerosis using human embryonic stem cells derived from mesenchymal stem cells, known as hES-MSCs.
Scientists at the University of Missouri have successfully transplanted and grown stem cells in pigs, pointing the way to a similar method that could eventually be used in people.
Researchers from Italy's San Raffaele Telethon Institute for Gene Therapy and Sangamo BioSciences have used a gene editing technique to correct a genetic defect in stem cells from an individual with X-linked severe combined immunodeficiency.
Despite the promise that stem cell technology has shown for regenerative medicine, heart attack patients who receive an injection of stem cells to regenerate damaged heart tissue may not actually benefit from the therapy.
New technology like organs-on-chips and bioprinted tissues have the potential to test the safety of drugs more accurately and cost-efficiently for a myriad of diseases. FierceBiotech Research highlights some organizations that are working on alternative drug testing technology.
Harvard scientists have combined their organ-on-a-chip technology with stem cells to produce functioning human heart tissue carrying an inherited cardiovascular disease, with the aim of creating a more personalized therapy regimen for individual patients.